Detalhe da pesquisa
1.
Extremely potent human monoclonal antibodies from COVID-19 convalescent patients.
Cell
; 184(7): 1821-1835.e16, 2021 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33667349
2.
Hybrid immunity improves B cells and antibodies against SARS-CoV-2 variants.
Nature
; 600(7889): 530-535, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34670266
3.
PRESTIGIO RING "a 59-year-old man with multidrug resistant HIV-1 infection failing a regimen including dolutegravir, rilpivirine, atazanavir/cobicistat: successful treatment tailoring based on genotypic and phenotypic resistance tests".
New Microbiol
; 47(1): 116-122, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38700893
4.
Blood telomere length gain in people living with HIV switching to dolutegravir plus lamivudine versus continuing triple regimen: a longitudinal, prospective, matched, controlled study.
J Antimicrob Chemother
; 78(9): 2315-2322, 2023 09 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37534393
5.
Non-B subtypes account for a large proportion of clustered primary HIV-1 infections in Italy.
Sex Transm Infect
; 99(1): 53-56, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35443987
6.
Effectiveness of integrase strand transfer inhibitors in HIV-infected treatment-experienced individuals across Europe.
HIV Med
; 23(7): 774-789, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35199909
7.
Is a radiological score needed to define the severity of Nontuberculous mycobacteria lung disease?
New Microbiol
; 45(4): 237-242, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36066215
8.
Effectiveness of integrase strand transfer inhibitor-based regimens in HIV-infected treatment-naive individuals: results from a European multi-cohort study.
J Antimicrob Chemother
; 76(9): 2394-2399, 2021 08 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34212176
9.
Efficacy and durability of two- vs. three-drug integrase inhibitor-based regimens in virologically suppressed HIV-infected patients: Data from real-life ODOACRE cohort.
HIV Med
; 22(9): 843-853, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34318591
10.
High rates of sustained virological response despite premature discontinuation of directly acting antivirals in HCV-infected patients treated in a real-life setting.
J Viral Hepat
; 28(3): 558-568, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33306247
11.
A challenging case of SARS-CoV-2- AIDS and Nocardiosis coinfection from the SMatteo COvid19 REgistry (SMACORE).
New Microbiol
; 44(2): 129-134, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-34151993
12.
Evolution of cellular HIV DNA levels in virologically suppressed patients switching to dolutegravir/lamivudine versus maintaining a triple regimen: a prospective, longitudinal, matched, controlled study.
J Antimicrob Chemother
; 75(6): 1599-1603, 2020 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32101614
13.
The University of California San Diego performance-based skills assessment: a useful tool to detect mild everyday functioning difficulties in HIV-infected patients with very good immunological condition.
J Neurovirol
; 26(6): 899-907, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32839950
14.
Determination of pentraxin 3 levels in cerebrospinal fluid during central nervous system infections.
Eur J Clin Microbiol Infect Dis
; 39(4): 665-670, 2020 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-31813079
15.
The impact of HIV infection and men who have sex with men status on hepatitis A infection: The experience of two tertiary centres in Northern Italy during the 2017 outbreak and in the 2009-2016 period.
J Viral Hepat
; 26(6): 761-765, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30801838
16.
Impact of genotypic susceptibility score on cART outcomes during primary HIV infection.
J Med Virol
; 91(10): 1891-1895, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31199538
17.
Hepatitis C virus-related factors associated WITH cognitive performance in HIV-HCV-coinfected patients.
J Neurovirol
; 25(6): 866-873, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31281946
18.
Liver fibrosis is associated with cognitive impairment in people living with HIV.
Infection
; 47(4): 589-593, 2019 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-30784024
19.
Atazanavir/ritonavir with lamivudine as maintenance therapy in virologically suppressed HIV-infected patients: 96 week outcomes of a randomized trial.
J Antimicrob Chemother
; 73(7): 1955-1964, 2018 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29668978
20.
Evolution of blood-associated HIV-1 DNA levels after 48 weeks of switching to atazanavir/ritonavir+lamivudine dual therapy versus continuing triple therapy in the randomized AtLaS-M trial.
J Antimicrob Chemother
; 72(7): 2055-2059, 2017 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28333353